XKRX:082270 (Korea (the Republic of))
Â
Ordinary Shares
â‚©
18920.00
(+16.93%)
Nov 28
Business Description
GemVax & KAEL Co Ltd
NAICS : 334413
SIC : 3674
ISIN : KR7082270000
Share Class Description:
XKRX:082270: Ordinary SharesCompare
Compare
Traded in other countries / regions
082270.Korea IPO Date
2005-06-24Description
GemVax & KAEL Co Ltd is primarily engaged in manufacturing and commercializing of coating resin and filters for semiconductors and panel display production. It offers chemical air filter, scrubber resin, and devices for preventing environmental contamination and eliminating harmful gas, for semiconductor and display industry. Its other business operations include research and development of anti-cancer immunotherapeutic and peptide drugs. The company organizes its business operations into three distinct segments: Environmental Pollution Control Business, IT Business, Bio-business. The company's product portfolio consists fundamental products, semiconductor, and display, equipment and system, fire evacuation mask 5aver.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.45 | |||||
| Equity-to-Asset | 0.52 | |||||
| Debt-to-Equity | 0.61 | |||||
| Debt-to-EBITDA | -0.97 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 3.54 | |||||
| Beneish M-Score | -4.99 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3.5 | |||||
| 3-Year EPS without NRI Growth Rate | -42.9 | |||||
| 3-Year Book Growth Rate | -7.2 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 82.42 | |||||
| 9-Day RSI | 73.03 | |||||
| 14-Day RSI | 65.71 | |||||
| 6-1 Month Momentum % | 28.04 | |||||
| 12-1 Month Momentum % | 1.79 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.16 | |||||
| Quick Ratio | 0.87 | |||||
| Cash Ratio | 0.65 | |||||
| Days Inventory | 69.28 | |||||
| Days Sales Outstanding | 27.28 | |||||
| Days Payable | 19.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -4.22 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.37 | |||||
| Operating Margin % | -62.09 | |||||
| Net Margin % | -85.01 | |||||
| FCF Margin % | -39.54 | |||||
| ROE % | -57.96 | |||||
| ROA % | -38.7 | |||||
| ROIC % | -32.61 | |||||
| ROC (Joel Greenblatt) % | -133.86 | |||||
| ROCE % | -46.29 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 11.9 | |||||
| PB Ratio | 10.01 | |||||
| Price-to-Tangible-Book | 10.71 | |||||
| EV-to-EBIT | -15.1 | |||||
| EV-to-EBITDA | -16.49 | |||||
| EV-to-Revenue | 12.36 | |||||
| EV-to-FCF | -26.9 | |||||
| Price-to-Median-PS-Value | 1.44 | |||||
| Earnings Yield (Greenblatt) % | -6.62 | |||||
| FCF Yield % | -3.3 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GemVax & KAEL Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 62,731.443 | ||
| EPS (TTM) (â‚©) | -1353 | ||
| Beta | 0.55 | ||
| Volatility % | 99.18 | ||
| 14-Day RSI | 65.71 | ||
| 14-Day ATR (â‚©) | 1633.731468 | ||
| 20-Day SMA (â‚©) | 13883 | ||
| 12-1 Month Momentum % | 1.79 | ||
| 52-Week Range (â‚©) | 9060 - 23300 | ||
| Shares Outstanding (Mil) | 39.68 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GemVax & KAEL Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GemVax & KAEL Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
GemVax & KAEL Co Ltd Frequently Asked Questions
What is GemVax & KAEL Co Ltd(XKRX:082270)'s stock price today?
The current price of XKRX:082270 is â‚©18920.00. The 52 week high of XKRX:082270 is â‚©23300.00 and 52 week low is â‚©9060.00.
When is next earnings date of GemVax & KAEL Co Ltd(XKRX:082270)?
The next earnings date of GemVax & KAEL Co Ltd(XKRX:082270) is .
Does GemVax & KAEL Co Ltd(XKRX:082270) pay dividends? If so, how much?
GemVax & KAEL Co Ltd(XKRX:082270) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers